ABSTRACT
Artificial intelligence, which is an approach based on mimicking the learning mechanisms inside the central nervous systems of living creatures, has widely spread to our daily life. Endocrinology and metabolism diseases is a field in which artificial intelligence has found considerable number of applications. In this article, in addition to a taxonomy of artificial intelligence, its current and potential/probable applications in endocrinology and metabolism diseases are presented and discussed.
Keywords: Artificial Intelligence Taxonomy, Endocrinology, Metabolism
References
1
Zeevi D, Korem T, Zmora N, et al. Personalized Nutrition by Prediction of Glycemic Responses. Cell. 2015;163:1079-1094.
2
Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35:556-564.
3
Leasher JL, Bourne RR, Flaxman SR, et al. Erratum. Global Estimates on the Number of People Blind or Visually Impaired by Diabetic Retinopathy: A Meta-analysis From 1990-2010. Diabetes Care. 2016;39:1643-1649.
4
Chang LY, Lee AC, Sue W. Prevalence of diabetic retinopathy at first presentation to the retinal screening service in the greater Wellington region of New Zealand 2006-2015, and implications for models of retinal screening. N Z Med J. 2017;130:78-88.
5
Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.
6
Abràmoff MD, Lavin PT, Birch M, Shah N, Folk JC. Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices. NPJ Digit Med. 2018;1:39.
7
Nimri R, Battelino T, Laffel LM, et al. Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes. Nat Med. 2020;26:1380-1384.
8
Phillip M, Battelino T, Atlas E, et al. Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med. 2013;368:824-833.
9
Tang F, Wang Y. Economic Model Predictive Control of Bihormonal Artificial Pancreas System Based on Switching Control and Dynamic R-parameter. J Diabetes Sci Technol. 2017;11:1112-1123.
10
Perreault L, Pan Q, Mather KJ, et al. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet. 2012;379:2243-2251.
11
Abbasi A, Peelen LM, Corpeleijn E, et al. Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study. BMJ. 2012;345:e5900.
12
Choi BG, Rha SW, Kim SW, et al. Machine Learning for the Prediction of New-Onset Diabetes Mellitus during 5-Year Follow-up in Non-Diabetic Patients with Cardiovascular Risks. Yonsei Med J. 2019;60:191-199.
13
Lai H, Huang H, Keshavjee K, et al. Predictive models for diabetes mellitus using machine learning techniques. BMC Endocr Disord. 2019;19:101.
14
Kopitar L, Kocbek P, Cilar L, et al. Early detection of type 2 diabetes mellitus using machine learning-based prediction models. Sci Rep. 2020;10:11981.
15
Contreras I, Vehi J. Artificial Intelligence for Diabetes Management and Decision Support: Literature Review. J Med Internet Res. 2018;20:e10775.
